Latest Market News

Cazaly Resources has identified anomalous gold mineralisation over a 700-metre strike at its Goongarrie Gold Project, prompting an expanded aircore drilling campaign to explore further along the Menzies Shear Zone.

Doctor Care Anywhere reports a 7.5% rise in consultations excluding secondary care and sustains positive cashflow for the second consecutive quarter, reaffirming ambitious medium-term growth targets.

Terra Metals has reported multiple new zones of massive and semi-massive sulfide mineralisation at its Southwest Prospect within the Dante Project, signalling a potentially large-scale, multi-metal magmatic system. Assay results are pending as drilling and geophysical surveys continue.

Metals X reported a 16.6% decline in tin production at its Renison operation for Q3 2025 due to equipment and processing challenges, while cash reserves rose to $279.5 million. The company continues advancing its Rentails project and maintains strategic investments.

Dreadnought Resources has upgraded its scoping study for the Star of Mangaroon gold project, increasing the initial production target by 24% to approximately 24,700 ounces at 8.3 g/t gold, while halving the maximum cash drawdown to $5.4 million.

Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.

Adslot Ltd reports solid progress in Q1 FY26, highlighting growth in its StoreFront and Marketplace platforms alongside a successful $989,000 capital raise to fuel expansion.

Lindian Resources secures official government confirmation that its Kangankunde Rare Earths Project is exempt from Malawi’s new raw mineral export ban, ensuring uninterrupted progress toward production.

Fitzroy River Corporation reported steady royalty income for the June quarter and highlighted significant progress on several royalty projects, including government approvals for Buru Energy’s Rafael Gas Project and a major equity raise for Endura Mining’s Snowy River Gold development.

INOVIQ Limited has raised $9.5 million to advance its pioneering ovarian cancer screening test and CAR-exosome therapeutic programs, backed by strong preclinical data and strategic partnerships.

Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.